Clinical Trials
4 trialsNCT06329323 2024-03-26
SUMMER
Imperial College London
Not yet recruiting
NCT03012620 2024-02-28
AcSé
UNICANCER
Phase 2 Completed
NCT02499952 2022-07-11
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Hoosier Cancer Research Network
Phase 2 Terminated
NCT04283773 2021-09-08
Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.
Assiut University
Completed